Haematology
Reticulocyte Production Index (RPI)
Marrow response corrected for anaemia and maturation.
Education and reference only. Not a substitute for clinical judgement, local policy or product labelling. Always verify before clinical use. Values are calculated in your browser and never stored.
Background
The reticulocyte production index (RPI), also called the corrected reticulocyte count, refines the raw reticulocyte percentage into a true measure of bone-marrow red-cell output in anaemia. Because the reticulocyte percentage is expressed relative to a reduced red-cell mass in anaemia, it overstates marrow activity; the RPI corrects for this using the haematocrit. It also corrects for the longer time immature reticulocytes spend in the circulation when released early, using a maturation factor that increases as haematocrit falls. The result distinguishes an appropriate marrow response from an inadequate one.
Interpreting the result
An RPI above 3 indicates an adequate, appropriate marrow response, as seen in haemolysis or acute blood loss where the marrow is working hard to replace red cells. An RPI below 2 indicates an inadequate (hypoproliferative) response, suggesting a marrow that is not compensating — for example in iron, B12 or folate deficiency, marrow failure or chronic disease. Values between 2 and 3 are borderline and should be interpreted in context. The index therefore helps separate anaemias of inadequate production from those of increased loss or destruction.
Worked example
A patient with anaemia has a reticulocyte count of 6% and a haematocrit of 25%. RPI = 6 × (25/45) ÷ 1.5 (maturation factor for Hct 25–34) = 6 × 0.556 ÷ 1.5 ≈ 2.2. This borderline-to-low value suggests the marrow response is not as vigorous as the raw 6% reticulocyte count implied.
Critical actions
RPI = retic% × (Hct/45) ÷ maturation factor (1 at Hct≥35, 1.5 at 25–34, 2 at 20–24, 2.5 if <20).
Pearls / pitfalls
- Modern analysers often report an automated absolute reticulocyte count or reticulocyte index, which can be used instead of manual RPI where available.
- Use the correct maturation factor for the haematocrit (1 at Hct ≥35, 1.5 at 25–34, 2 at 20–24, 2.5 if <20) — using the wrong factor distorts the result.
- The RPI assumes a normal haematocrit reference of about 45; very large transfusions or recent bleeding can confound interpretation.
- A low RPI points to a hypoproliferative cause but does not identify which one — further tests (iron studies, B12/folate, blood film) are needed.
Evidence & validation
The RPI is a standard, long-established haematological correction taught in major textbooks; it formalises the maturation- and haematocrit-correction needed to interpret reticulocyte counts in anaemia.
Frequently asked questions
Why correct the reticulocyte count at all?
In anaemia the reticulocyte percentage is measured against a reduced number of red cells, so it overstates how active the marrow is. The RPI corrects for the low haematocrit and for early release of immature reticulocytes, giving a truer measure of marrow output.
What RPI suggests the marrow is responding well?
An RPI above 3 indicates an adequate response, typical of haemolysis or recent blood loss. A value below 2 suggests the marrow is not compensating adequately.
What does a low RPI mean?
A low RPI (below 2) indicates a hypoproliferative anaemia — the marrow is not producing enough red cells. Causes include iron, B12 or folate deficiency, marrow failure and anaemia of chronic disease, which then need targeted investigation.
How is the maturation factor chosen?
The maturation factor increases as the haematocrit falls: 1 at a haematocrit of 35 or above, 1.5 at 25–34, 2 at 20–24, and 2.5 below 20. This accounts for immature reticulocytes circulating longer in more severe anaemia.
References
- RPI = reticulocyte % × (haematocrit ÷ 45) ÷ maturation factor — standard maturation-corrected reticulocyte calculation.
- Hoffbrand AV, Moss PAH. Hoffbrand's Essential Haematology. Wiley-Blackwell (reticulocyte response and marrow output).
Related calculators
Need a calculator we don't have — or a custom tool?
We build evidence-led clinical calculators, dashboards and reference tools for teams.